Veeva Systems (VEEV) cash flow statement

Health Care Technology · NYSE · Health Care

$288.41 -3.63% Close Nov 17, 2026 Live

TrendArc score 68 of 100 · Health 8.7 · Momentum 7.3 · Moat 6.1 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to January 31, 2026

$1.4 billion

up 29.6% from the year before

Veeva Systems generated $1.4 billion of free cash flow in the fiscal year to January 2026: $1.4 billion of cash from operations less $29 million of capital spending. That was 43.4% of revenue, against 38.9% the year before. Over the last four quarters, to July 31, 2026, it was $1.6 billion.

What stands out

  • Free cash flow exceeded net income in each of the last five fiscal years: $4.9 billion against $3.1 billion in total.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 10 fiscal years

$500M$1.00B$1.50B2017201820192020202120222023202420252026$137MFree cash flow $1.39BNet income $909M$500M$1.00B$1.50B20182020202220242026Free cash flow $1.39BNet income $909M

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to January 31, 2026

  1. Cash from operations 1.42
  2. Capital spending -0.03
  3. Free cash flow 1.39
  4. Investments bought and sold, net -1.08
  5. Net share issuance 0.08
  6. Debt and other -0.09
  7. Net change in cash 0.30

In billions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 10 fiscal years

In billions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Jul 2026
Jan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
Operating activities
Net income0.910.710.530.490.430.380.300.230.150.08
Depreciation and amortisation0.050.050.040.040.040.040.030.010.010.01
Stock-based pay0.490.470.440.390.350.230.190.120.080.050.04
Working capital and other items-0.02-0.11-0.05-0.100.06-0.05-0.01-0.010.010.01
Cash from operations1.671.421.090.910.780.760.550.440.310.230.14
Investing activities
Capital spending-0.03-0.03-0.02-0.03-0.01-0.01-0.010.00-0.01-0.01-0.01
Businesses bought and sold, net0.000.000.000.00-0.010.00-0.450.000.000.00
Investments bought and sold, net-1.08-0.68-1.05-0.99-0.32-0.32-0.06-0.09-0.14-0.09
Cash from investing-1.10-0.70-1.08-1.01-0.35-0.33-0.52-0.10-0.15-0.10
Financing activities
Debt issued or repaid, net0.000.000.000.000.000.000.000.000.000.00
Shares issued less bought back-0.550.080.110.060.040.050.030.010.030.020.01
Dividends paid0.000.000.000.000.000.000.000.000.000.000.00
Other financing-0.09-0.08-0.08-0.06-0.060.000.000.000.000.03
Cash from financing-0.010.03-0.02-0.020.000.030.010.030.020.04
Net change in cash0.300.41-0.18-0.250.410.25-0.070.230.100.09
Free cash flow
Free cash flow1.641.391.070.890.770.750.540.430.300.220.14
Free cash flow margin47.4%43.4%38.9%37.4%35.6%40.5%37.0%39.2%34.9%32.2%24.8%
Free cash flow per share$8.30$6.47$5.41$4.72$4.62$3.38$2.74$1.93$1.45$0.92
Free cash flow less stock-based pay0.910.630.490.420.520.360.320.220.170.10

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

Veeva Systems against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Veeva SystemsVEEV Jan 2026$1.39B43.4%
Quest DiagnosticsDGX Dec 2025$1.36B12.3%
HCA HealthcareHCA Dec 2025$7.69B10.2%
LabcorpLH Dec 2025$1.21B8.6%
CignaCI Dec 2025$8.39B3.1%
CenteneCNC Dec 2025$4.32B2.2%
Cardinal HealthCAH Jun 2026$4.56B1.8%
Elevance HealthELV Dec 2025$3.17B1.6%
HumanaHUM Dec 2025$398M0.3%
Peer median2.6%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow Veeva Systems with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Veeva Systems from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.